News & Articles

Explore cutting-edge technologies, free downloads, and expert insight to support your research

We hear from Kevin Entzminger on how Abwiz Bio is developing next-gen antibody therapeutics to help answer fundamental questions in science

A flow cytometry technician shares how live high-speed image capture increases the range of information obtained from limited sample materials

As the first laboratory to validate Ki-67 IHC MIB-1 pharmDx Quest plans to make testing available nationally by the end of October 2021

Which new products helped to accelerate your lab work this year?

Gain insights on a range of current topics, including clinical microbiology, vaccine design, cell viability and more

Gain insights on topics from immunotyping and cell sorting to clinical QC, 3D imaging and more

We’ve rounded up the latest clinical news and technological advancements which made waves at this year’s conference

The panels complete Bio-Rad’s set of Bio-Plex™ Pro Multiplex SARS-CoV-2 Human Serology Panels for detection of antibodies against four SARS-CoV-2 antigens

Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease.

Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using EUROIMMUN tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection

Introduced at AACC, the VeraPrep Antibody Detection Kit enables researchers to measure antibodies against any antigen of interest in serum, plasma or saliva

Watch world-leading scientists online, October 5, to discover the latest tools and techniques advancing Alzheimer's research, single cell characterization, biomarker discovery and more

Watch this on-demand webinar to learn how the iQue® Advanced Flow Cytometry Platform and associated reagent kits can be used to quantify T cell response in MLR

Discover innovative POC technology designed to meet today’s emergency care needs and inform effective management of cardiac patients

Watch this on-demand webinar to learn about the cell avidity technology advancing CAR-T cell therapy research

Prof. Akiko Iwasaki explores the differences in the immune responses of COVID-19 patients with moderate and severe disease

A large proportion of patients with impaired immune systems mount a low, or undetectable, immune response after two doses of COVID-19 vaccine

Using cancer biomarkers, the VENTANA MMR RxDx Panel helps determine which tumor patients may benefit from GSK immunotherapy

Adults who have received a double vaccination are 47% less likely to have long COVID

Keep up to date with the latest technologies and techniques advancing clinical diagnostics